-
公开(公告)号:EP1824514A2
公开(公告)日:2007-08-29
申请号:EP05852564.3
申请日:2005-11-30
申请人: CENTOCOR, INC.
发明人: CARTON, Jill , CUNNINGHAM, Mark , DAS, Anuk , DUFFY, Karen , KNIGHT, David, M. , LAMB, Roberta , MBOW, Mouhamadou, L. , RAGHUNATHAN, Gopalan , SAN MATEO, Lani , SARISKY, Robert, T. , STOWELL, Nicole , SWEET, Raymond , ZHAO, Shanrong , CHEN, Shizhong , GILES-KOMAR, Jill , PICHA, Kristen , STOJANOVIC-SUSULIC, Vedrana , GOLETZ, Theresa, J.
IPC分类号: A61K39/395 , C07K16/28
CPC分类号: C07K16/2896 , A61K2039/505 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/76 , C07K2317/92
摘要: Toll Like Receptor 3 (TLR3) antagonists, polynucleotides encoding TLR3 antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.
-
公开(公告)号:EP1945657A2
公开(公告)日:2008-07-23
申请号:EP06846186.2
申请日:2006-10-30
申请人: CENTOCOR, INC.
IPC分类号: C07K14/00
CPC分类号: C07K14/705 , A61K38/00 , A61K48/00
摘要: TLR3 glycosylation site muteins, nucleic acids encoding the muteins, and methods of modulating TLR3 activity in a cell are disclosed.
摘要翻译: 公开了TLR3糖基化位点突变蛋白,编码突变蛋白的核酸以及调节细胞中TLR3活性的方法。
-
公开(公告)号:EP1696952A1
公开(公告)日:2006-09-06
申请号:EP04815276.3
申请日:2004-12-21
申请人: CENTOCOR, INC.
发明人: DILLON, Susan, B. , DEL VECCHIO, Alfred, Michael , HUANG, Chichi , O'NEIL, Karyn, T. , SARISKY, Robert, T.
IPC分类号: A61K39/00 , A61K39/395 , A61K39/21
CPC分类号: C07K14/005 , C07K16/00 , C07K2317/52 , C07K2317/56 , C07K2319/00 , C07K2319/035 , C07K2319/31 , C07K2319/74 , C12N2740/16122 , C12N2740/16222
摘要: HIV gp41 mimetibody polypeptides and encoding polynucleotides are disclosed. Methods of utilizing the polypeptides to reduce or inhibit HIV fusion with a cell membrane and entry into target cells are also disclosed.
-
公开(公告)号:EP1945820A2
公开(公告)日:2008-07-23
申请号:EP06846174.8
申请日:2006-10-26
申请人: CENTOCOR, INC.
发明人: DUFFY, Karen, E. , HUANG, Chong, C. , LAMB, Roberta , MBOW, Mouhamadou, L. , SARISKY, Robert, T. , SAN, Mateo, Lani
CPC分类号: C07K16/2896 , A61K2039/505 , C07K2317/56 , C07K2317/567 , C07K2317/75
摘要: Toll Like Receptor 3 (TLR3) modulators, such as antibodies, polynucleotides encoding TLR3 antibodies or fragments thereof, and methods of making and using the foregoing are disclosed.
-
-
-